These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18182451)

  • 1. Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I.
    Li G; Del Rincon JP; Jahn LA; Wu Y; Gaylinn B; Thorner MO; Liu Z
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1379-85. PubMed ID: 18182451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
    Thum T; Hoeber S; Froese S; Klink I; Stichtenoth DO; Galuppo P; Jakob M; Tsikas D; Anker SD; Poole-Wilson PA; Borlak J; Ertl G; Bauersachs J
    Circ Res; 2007 Feb; 100(3):434-43. PubMed ID: 17234973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.
    Nielsen C; Gormsen LC; Jessen N; Pedersen SB; Møller N; Lund S; Jørgensen JO
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2842-50. PubMed ID: 18460563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.
    Fryburg DA
    J Clin Invest; 1996 Mar; 97(5):1319-28. PubMed ID: 8636445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute peripheral metabolic effects of intraarterial leg infusion of somatostatin in healthy young men.
    Krusenstjerna-Hafstrøm T; Vestergaard ET; Buhl M; Nielsen R; Clasen BF; Nielsen S; Møller N; Pedersen SB; Jørgensen JO
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2581-9. PubMed ID: 21632809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion.
    Jessen N; Djurhuus CB; Jørgensen JO; Jensen LS; Møller N; Lund S; Schmitz O
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E194-9. PubMed ID: 15339744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of growth hormone on vascular function in human subjects.
    Napoli R; Guardasole V; Angelini V; D'Amico F; Zarra E; Matarazzo M; Saccà L
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2817-20. PubMed ID: 12788893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I.
    Thum T; Fleissner F; Klink I; Tsikas D; Jakob M; Bauersachs J; Stichtenoth DO
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4172-9. PubMed ID: 17726074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term administration of growth hormone (GH) lowers blood pressure by activating eNOS/nitric oxide (NO)-pathway in male hypophysectomized (Hx) rats.
    Nyström HC; Klintland N; Caidahl K; Bergström G; Wickman A
    BMC Physiol; 2005 Nov; 5():17. PubMed ID: 16271154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
    Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
    Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery.
    Bjarnason R; Wickelgren R; Hermansson M; Hammarqvist F; Carlsson B; Carlsson LM
    J Clin Endocrinol Metab; 1998 May; 83(5):1566-72. PubMed ID: 9589657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt phosphorylation in lymphocytes provides an index of in vitro insulin-like growth factor I sensitivity associated with growth hormone-induced growth.
    Lotton C; Rodrigue D; Elie C; Rothenbühler A; Lahlou N; Le Stunff C; Bougnères P
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1458-63. PubMed ID: 18252783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.
    Sadowski CL; Wheeler TT; Wang LH; Sadowski HB
    Endocrinology; 2001 Sep; 142(9):3890-900. PubMed ID: 11517167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults.
    Krusenstjerna-Hafstrøm T; Clasen BF; Møller N; Jessen N; Pedersen SB; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2548-57. PubMed ID: 21613350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I, actin, and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.
    Welle S; Thornton C
    J Endocrinol; 1997 Oct; 155(1):93-7. PubMed ID: 9390011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression.
    Ge X; Yu J; Jiang H
    J Anim Sci; 2012 Apr; 90(4):1126-33. PubMed ID: 22100600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms.
    O'Connell T; Clemmons DR
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4356-60. PubMed ID: 12213898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive effects of insulin-like growth factor-1 and beta-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells.
    Isenovic ER; Divald A; Milivojevic N; Grgurevic T; Fisher SE; Sowers JR
    Metabolism; 2003 Apr; 52(4):482-7. PubMed ID: 12701063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
    Frost RA; Nystrom GJ; Lang CH
    Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
    Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H
    Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.